BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30228186)

  • 1. K-Ras Lys-42 is crucial for its signaling, cell migration, and invasion.
    Choi BH; Philips MR; Chen Y; Lu L; Dai W
    J Biol Chem; 2018 Nov; 293(45):17574-17581. PubMed ID: 30228186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras sumoylation in cell signaling and transformation.
    Dai W; Xie S; Chen C; Choi BH
    Semin Cancer Biol; 2021 Nov; 76():301-309. PubMed ID: 33812985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMOylation of Grb2 enhances the ERK activity by increasing its binding with Sos1.
    Qu Y; Chen Q; Lai X; Zhu C; Chen C; Zhao X; Deng R; Xu M; Yuan H; Wang Y; Yu J; Huang J
    Mol Cancer; 2014 Apr; 13():95. PubMed ID: 24775912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small G proteins Rac1 and Ras regulate serine/threonine protein phosphatase 5 (PP5)·extracellular signal-regulated kinase (ERK) complexes involved in the feedback regulation of Raf1.
    Mazalouskas MD; Godoy-Ruiz R; Weber DJ; Zimmer DB; Honkanen RE; Wadzinski BE
    J Biol Chem; 2014 Feb; 289(7):4219-32. PubMed ID: 24371145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rasfonin, a novel 2-pyrone derivative, induces ras-mutated Panc-1 pancreatic tumor cell death in nude mice.
    Xiao Z; Li L; Li Y; Zhou W; Cheng J; Liu F; Zheng P; Zhang Y; Che Y
    Cell Death Dis; 2014 May; 5(5):e1241. PubMed ID: 24853419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Radil as a Ras binding partner and putative activator.
    Choi BH; Kou Z; Colon TM; Chen CH; Chen Y; Dai W
    J Biol Chem; 2021; 296():100314. PubMed ID: 33482197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
    Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
    Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic Ras abrogates MEK SUMOylation that suppresses the ERK pathway and cell transformation.
    Kubota Y; O'Grady P; Saito H; Takekawa M
    Nat Cell Biol; 2011 Mar; 13(3):282-91. PubMed ID: 21336309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
    Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
    J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-ras mutation promotes ionizing radiation-induced invasion and migration of lung cancer in part via the Cathepsin L/CUX1 pathway.
    Wang L; Zhao Y; Xiong Y; Wang W; Fei Y; Tan C; Liang Z
    Exp Cell Res; 2018 Jan; 362(2):424-435. PubMed ID: 29246726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIAS1-mediated sumoylation of focal adhesion kinase activates its autophosphorylation.
    Kadaré G; Toutant M; Formstecher E; Corvol JC; Carnaud M; Boutterin MC; Girault JA
    J Biol Chem; 2003 Nov; 278(48):47434-40. PubMed ID: 14500712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 13. Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38.
    Dreissigacker U; Mueller MS; Unger M; Siegert P; Genze F; Gierschik P; Giehl K
    Cell Signal; 2006 Aug; 18(8):1156-68. PubMed ID: 16257181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    Mol Cancer; 2005 Oct; 4():37. PubMed ID: 16209712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through mitogen-activated protein kinase signaling pathways.
    Matsuo Y; Campbell PM; Brekken RA; Sung B; Ouellette MM; Fleming JB; Aggarwal BB; Der CJ; Guha S
    Mol Cancer Res; 2009 Jun; 7(6):799-808. PubMed ID: 19509115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal Growth Factor Receptor Signaling to the Mitogen Activated Protein Kinase Pathway Bypasses Ras in Pancreatic Cancer Cells.
    Lee S; Heinrich EL; Lu J; Lee W; Choi AH; Luu C; Chung V; Fakih M; Kim J
    Pancreas; 2016 Feb; 45(2):286-92. PubMed ID: 26262587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells.
    Hoang VT; Nyswaner K; Torres-Ayuso P; Brognard J
    J Biol Chem; 2020 Jun; 295(25):8470-8479. PubMed ID: 32358059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndecan-1 suppresses cell growth and migration via blocking JAK1/STAT3 and Ras/Raf/MEK/ERK pathways in human colorectal carcinoma cells.
    Wang S; Zhang X; Wang G; Cao B; Yang H; Jin L; Cui M; Mao Y
    BMC Cancer; 2019 Nov; 19(1):1160. PubMed ID: 31783811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism.
    Peng DH; Kundu ST; Fradette JJ; Diao L; Tong P; Byers LA; Wang J; Canales JR; Villalobos PA; Mino B; Yang Y; Minelli R; Peoples MD; Bristow CA; Heffernan TP; Carugo A; Wistuba II; Gibbons DL
    Sci Transl Med; 2019 Mar; 11(483):. PubMed ID: 30867319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAS GTPases are modified by SUMOylation.
    Choi BH; Chen C; Philips M; Dai W
    Oncotarget; 2018 Jan; 9(4):4440-4450. PubMed ID: 29435114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.